Ariad loses $65M patent appeal against Eli Lilly
Monday’s decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly’s osteoporosis
drug Evista and sepsis medicine Xigris.
Monday’s decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly’s osteoporosis
drug Evista and sepsis medicine Xigris.
Attorneys general in at least 13 states have signaled they intend to challenge the constitutionality of the legislation in
court.
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.
Drugmakers and insurers could gain millions of customers under the legislation, but the industry also will pay new fees and
face stricter rules that may shrink profit and fuel mergers.
To pay for the changes, the legislation includes more than $400 billion in higher taxes over a decade, roughly half of it
from a new Medicare payroll tax on individuals with incomes over $200,000 and couples over $250,000.
Former WellPoint Inc. leader Larry Glasscock has joined the board of directors of the Indianapolis-based real estate giant.
The peanut-borne salmonella outbreak of 2009 raised awareness about the risk of illness from unlikely sources. Unfortunately,
that wasn’t the last time a seemingly innocuous ingredient made people sick, and prompted recalls.
Netherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
Companion Diagnostics Inc. moves from Connecticut to the IU Emerging Technologies Center, hopes to create 30 high-paying jobs
by 2014.
Indianapolis-based health insurer expects revenue, profit to fall as persistently high unemployment reduces employer-sponsored
insurance enrollment.
Historically low bond rates will help the parent corporation of Wishard Health Services build hospital for less money
than expected.
Indiana health-related companies were somewhat absent from the lobbying bonanza that gripped Washington, D.C., in 2009. For
all the heat and light about health reform, major Indiana companies actually spent slightly less to lobby Congress.
St. Francis Hospital & Health Centers has acquired Joint Replacement Surgeons of Indiana, a six-doctor practice that
operates in St. Francis' Mooresville hospital.
Pharmaceuticals stolen Sunday morning could be worth up to $75 million.
Eli Lilly & Co., the maker of the impotence pill Cialis, bought exclusive rights from Australia’s Acrux Ltd. to
an underarm testosterone lotion called Axiron for men with limited sex drive due to low levels of the hormone.
Indiana Health Information Technology Inc. will use the money to electronically link the medical records of Indiana's
five health information exchanges.
Indianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing
assets are transferred, but the deal could be worth millions more.
Blue Cross of California has been ordered to reimburse a man $206,000 after he paid for his own liver transplant.
Indiana Rep. Mike Pence told a crowd of "tea party" supporters Monday that Democrats in Congress don’t have
enough votes to pass President Barack Obama’s health care reform legislation.
Indianapolis-based WellPoint Inc., the nation's largest health insurer based on membership, spent $1.2 million lobbying
the federal government in the fourth quarter of 2009 as it weighed in on several topics tied to the health care overhaul debate.